GrafTech (EAF) Q1 2026 Earnings Transcript

GrafTech reported a $43 million net loss, or $1.66 per share, with negative adjusted EBITDA of $14 million, but management highlighted improving pricing momentum after announcing a $600 to $1,200 per metric ton increase on uncommitted graphite electrode volume. More than 85% of 2026 sales are already committed, liquidity ended at $329 million, and the company expects 5% to 10% sales volume growth for the year. The outlook is supported by trade-case progress, but near-term results remain pressured by lower ASPs, higher cash costs of $3,848 per ton, and energy/decant oil volatility tied to Middle East disruptions.

Analysis

The setup is more interesting as a pricing bridge than as a current earnings recovery. The company is still mostly living off legacy contracts, so the Q1 print understates the operating leverage that could show up in Q3/Q4 if the announced price reset sticks; that creates a classic “visible pain now, optionality later” tape. The market is likely underestimating how much of the rerating depends on procurement cycle timing rather than end-demand, which means the next 60-120 days matter less than the tender cadence into 2027 negotiations.

The cleaner second-order winner is not necessarily EAF itself, but downstream steelmakers that rely on just-in-time imported electrodes and have less ability to re-price finished steel quickly. If duties land on schedule, the immediate effect is less import substitution and more a higher domestic clearing price, which should compress margins for smaller EAF operators before it helps EAF penetration at the macro level. In other words, trade protection is bullish for pricing power, but the first-order burden gets pushed to customers before it becomes a volume tailwind for the supplier base.

The cost story cuts both ways. Fixed European energy hedges reduce near-term earnings sensitivity, but decant oil is the real variable to watch because it is the only input that can move the cost curve fast enough to overwhelm the announced price hike if oil stays elevated into H2. The contrarian risk is that the market has already started to price in a straight-line improvement, while the actual path is lumpy: one bad oil move, one delayed duty ruling, or one weaker tender round could push the recovery out by another quarter or two.

Key Decisions for Investors

• Long EAF into Q3 pricing inflection, but size as a catalyst trade rather than a core quality position; best entry is on any pullback before July customs/tariff milestones. Upside case is material margin leverage if price resets land across the uncommitted book, but downside is another quarter of legacy ASP drag.
• Buy EAF Sep/Jan call spreads instead of outright stock to express the second-half reprice with defined downside. The structure fits the timing mismatch: near-term earnings remain weak, while the real optionality is tied to contract resets and duty decisions later in 2026.
• Pair trade: long EAF / short a basket of high-cost EAF steel producers or exposed mini-mill names where electrode costs are a larger share of conversion margin. The thesis is that trade remedies lift electrode pricing faster than steel pricing, squeezing weaker buyers first.
• If looking for a cleaner commodity hedge, consider long positions in names leveraged to needle coke / petroleum byproducts only if they benefit from supply dislocation without similar customer concentration. Otherwise, avoid chasing the move: the market could misread a temporary tender win as a durable margin reset.